Background The number of older adults has been constantly growing around the globe.
Consequently, multimorbidity and related polypharmacy have become an increasing …

Cardiovascular diseases (CVDs) are a leading cause of death globally. This article explores
the evidence surrounding community pharmacist interventions to reduce cardiovascular …

Background: Polypharmacy paves the way for non-adherence, adverse drug reactions,
negative health outcomes, increased use of healthcare services and rising costs. Since it is …

Abstract Background General practitioners (GPs) increasingly manage patients with
multimorbidity but report challenges in doing so. Patients describe poor experiences with …

Background Managing polypharmacy is a challenge for healthcare systems globally. It is
also a health inequality concern as it can expose some of the most vulnerable in society to …

Background Drug treatment of older people is still potentially inappropriate in many cases as
multimorbidity and related polypharmacy are highly prevalent. To increase the quality of …

Frailty is a geriatric condition associated with increased vulnerability to adverse drug events
and medication-related harm. Existing clinical practice guidelines rarely provide medication …

BACKGROUND Tackling problematic polypharmacy requires tailoring the use of medicines
to individual needs and circumstances. This may involve stopping medicines (deprescribing) …

Methods: This qualitative descriptive study entailed 1–1 interviews with older adults with
multimorbidity receiving community based primary health care in Canada and New Zealand …

Multimorbidity and widespread use of clinical guidelines are the main causes for highly
prevalent polypharmacy in older people [1, 2]. Polypharmacy has been identified as a major …